Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ENMD-0995 trial for patients with multiple myeloma under way

Nov. 19, 2002

GC-C technology has potential as marker and target for gastric and esophageal cancers

Nov. 19, 2002

Helsinn grants CJ Corp. license and distribution rights for palonosetron in Korea

Nov. 19, 2002

New antiproliferative compounds isolated from fungal species

Nov. 19, 2002

Grant awarded for first clinical trial of squalamine in the treatment of prostate cancer

Nov. 18, 2002

Cell Therapeutics earns milestone payment

Nov. 18, 2002

ChromaVision and NewBiotics to collaborate on cancer therapeutic development

Nov. 18, 2002

Phase II trial of TNFerade initiated in patients with esophageal cancer

Nov. 18, 2002

Chemoprotective agent heads for clinical trials at ProMetic

Nov. 18, 2002

Compounds that directly inhibit the androgen receptor discovered at Praecis

Nov. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.